Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023.
| العنوان: | Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023. |
|---|---|
| المؤلفون: | Spengler JR; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: JSpengler@cdc.gov., Carter K; Evotec US, Princeton, NJ, USA., Delang L; Laboratory of Virology and Chemotherapy, Mosquito Virology Team, KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Leuven, Belgium., Durantel D; Centre International de Recherche en Infectiologie (CIRI), Inserm_U1111, CNRS_UMR5308, Université Claude Bernard Lyon 1, F-69007, Lyon, France., Gowen BB; Institute for Antiviral Research and Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT, USA., Herrero LJ; The Institute for Glycomics, Griffith University, Southport, QLD, Australia., Hurst B; Institute for Antiviral Research and Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT, USA., Janeba Z; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, Prague, Czech Republic., Jordan R; Global Health Discovery & Translational Sciences, Bill & Melinda Gates Foundation, Seattle, WA, USA., Luo D; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; National Centre for Infectious Diseases, Singapore, Singapore., Meier C; Organic Chemistry, Department of Chemistry, Faculty of Sciences, University of Hamburg, Hamburg, Germany., Moffat J; Department of Microbiology & Immunology, SUNY Upstate Medical University, Syracuse, NY, USA., Rocha-Pereira J; KU Leuven-Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Seley-Radtke KL; Department of Chemistry & Biochemistry, University of Maryland, Baltimore County, Baltimore, MD, USA., Welch SR; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA., Schang LM; Baker Institute and Department of Microbiology and Immunology, Cornell University, Ithaca, NY, USA. |
| المصدر: | Antiviral research [Antiviral Res] 2023 Sep; Vol. 217, pp. 105678. Date of Electronic Publication: 2023 Jul 24. |
| نوع المنشور: | Congress |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9096 (Electronic) Linking ISSN: 01663542 NLM ISO Abbreviation: Antiviral Res Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Amsterdam : Elsevier Original Publication: [Amsterdam ; New York : Elsevier/North-Holland Biomedical Press, c1981- |
| مواضيع طبية MeSH: | Antiviral Agents*/pharmacology , Antiviral Agents*/therapeutic use , COVID-19*, Humans ; Iron-Dextran Complex ; Pandemics ; SARS-CoV-2 |
| مستخلص: | The 36th International Conference on Antiviral Research (ICAR), sponsored by the International Society for Antiviral Research (ISAR), was held March 13-17, 2023, in Lyon, France, and concurrently through an interactive remote meeting platform. Here we provide a report summarizing the presentations at the 36th ICAR, including the ISAR speaker awards. We also detail special events, sessions, and additional awards conferred at the meeting. ICAR returned to in-person meetings in 2022, convening in Seattle, WA, USA. The 36th ICAR is the first in-person meeting of the society in Europe since the beginning of the COVID-19 pandemic, which restricted most events to virtual attendance to help mitigate the spread and subsequent public health impact of SARS-CoV-2. An exceptionally high number of registrants and record attendance at this year's ICAR, along with a vast array of demonstrable expertise in a variety of antiviral research-related fields, reflected a strong and growing antiviral research community committed to improving health outcomes from viral diseases, including SARS-CoV-2, and to future pandemic preparedness. This report highlights the breadth of expertise, quality of research, and notable advancements that were contributed by members of ISAR and other participants at the meeting. ICAR aims to continue to provide a platform for sharing information, fostering collaborations, and supporting trainees in the field of antiviral research. The 37th ICAR will be held in Gold Coast, Australia, May 20-24, 2024. Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Published by Elsevier B.V.) |
| References: | Antiviral Res. 2019 Sep;169:104550. (PMID: 31302149) Antiviral Res. 2013 Oct;100(1):276-85. (PMID: 23973733) Antiviral Res. 2014 Nov;111:143-53. (PMID: 25218950) IDrugs. 2003 Jun;6(6):515-7. (PMID: 12861974) Antiviral Res. 2018 Oct;158:88-102. (PMID: 30086336) Antiviral Res. 2017 Jan;137:23-40. (PMID: 27815125) Antiviral Res. 2023 Mar;211:105521. (PMID: 36596323) IDrugs. 2003 Jun;6(6):512-4. (PMID: 12861972) Antiviral Res. 2017 Sep;145:184-196. (PMID: 28774800) Antivir Chem Chemother. 2011 Oct 07;22(2):75-85. (PMID: 21984687) Antiviral Res. 2015 Nov;123:172-87. (PMID: 26431686) Antivir Chem Chemother. 2022 Jan-Dec;30:20402066221130853. (PMID: 36305015) |
| معلومات مُعتمدة: | CC999999 United States ImCDC Intramural CDC HHS |
| المشرفين على المادة: | 0 (Antiviral Agents) 9004-66-4 (Iron-Dextran Complex) |
| تواريخ الأحداث: | Date Created: 20230726 Date Completed: 20230829 Latest Revision: 20240902 |
| رمز التحديث: | 20240902 |
| مُعرف محوري في PubMed: | PMC11268725 |
| DOI: | 10.1016/j.antiviral.2023.105678 |
| PMID: | 37494979 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1872-9096 |
|---|---|
| DOI: | 10.1016/j.antiviral.2023.105678 |